首页> 外文期刊>Topics in companion animal medicine >Macrocyclic Lactones and Dirofilaria immitis Microfilariae
【24h】

Macrocyclic Lactones and Dirofilaria immitis Microfilariae

机译:大环内酯和丝虫病

获取原文
获取原文并翻译 | 示例
       

摘要

Although there has been extensive veterinary focus on both the effectiveness of macrocyclic lactones for heartworm prevention in dogs and their adulticidal effects, little attention has been directed to their effects on heartworm microfilariae. With routine use of macrocyclic lactones, in some cases knowingly, in dogs with existing heartworm infections, veterinarians should recognize the benefits, and possible complications, arising from this behavior. Macrocyclic lactones remain our only class of heartworm prevention available, and preserving their effectiveness is critical. Drugs in this class share common traits: there are currently no Food and Drug Administration approved microfilaricides in the US marketplace, but because all macrocyclic lactones have microfilaricidal properties (to varying degrees), they are widely used by veterinarians for this purpose. Originally formulated to be used in dogs without patent heartworm infections, all have been demonstrated as safe to use at label doses, and higher, in microfilaremic dogs. All of the product labels indicate that dogs should be tested for heartworm infection before starting preventive therapy. Although microfilaricidal, microfilariae reduction may take many months to occur, and sonic dogs may never clear. The effects of macrocyclic lactones on the numbers of circulating microfilariae may be due to several different underlying causes (i.e., direct effect on the nervous system, affecting stages found in the uterus of the female worms), but the details of all mechanisms by which microfilariae are killed and/or cleared in dogs treated with macrocyclic lactones have not yet been fully elucidated. Some 10% to 20% of heartworm-infected dogs that begin monthly heartworm preventive treatment without adulticide therapy will have the continued and persistent presence of circulating microfilariae, and the concern is that this may be selecting for resistance to these molecules. The veterinary literature now includes evidence of increased genotypic homozygosity in specific dogs in one area of the country for a marker gene associated with macrocyclic lactone resistance in nematodes of ruminants. This article will review the biology of microfilariae, as well as the evolution of diagnostic testing for heartworm infection. The effects of macrocyclic lactones on microfilaria behavior and survival will be discussed, as well as the use and effects of macrocyclic lactones in microfilaremic dogs, with or without adulticide treatment. The effect of doxycycline on heartworm microfilariae, optimal testing methodologies, and verification of effective clearance of microfilariae after adulticide treatment and microfilaricidal therapy so that dogs do not remain a potential source of infection for other dogs are all covered
机译:尽管在兽医学上已经广泛关注大环内酯在犬中预防心丝虫的功效及其杀虫效果,但是很少关注它们对丝虫微丝虫的作用。已知在某些情况下,常规使用大环内酯在已患有心丝虫感染的狗中,兽医应认​​识到这种行为所带来的好处和可能的并发症。大环内酯仍然是我们预防心丝虫的唯一一类,因此保持其有效性至关重要。此类药物具有共同的特征:美国市场上目前没有食品和药物管理局批准的微杀线虫剂,但是由于所有大环内酯都具有(不同程度的)微杀线虫性能,因此兽医广泛使用它们。最初被配方用于无专利性心丝虫感染的狗,所有这些均已证明可以安全地以标签剂量使用,甚至更高剂量用于微丝热狗。所有产品标签均表明,在开始预防性治疗之前,应该对狗进行心丝虫感染测试。尽管减少了微丝杀伤,但减少微丝aria病可能需要几个月的时间,而且声波犬可能永远也不会清除。大环内酯对循环微丝aria数量的影响可能是由于几种不同的潜在原因(即对神经系统的直接影响,影响了雌性蠕虫子宫中发现的阶段),但是微丝all的所有机制均已详述用大环内酯治疗的狗中的Aβ被杀死和/或清除还没有被完全阐明。大约每月有20%到20%的经心丝虫感染的狗开始进行每月的心丝虫预防治疗而未使用成年杀虫剂治疗,它们会持续存在循环微丝aria病,并且担心的是,这可能是针对这些分子的抗药性。现在,兽医文献包括在该国一个地区的特定犬中,与反刍动物线虫中大环内酯抗性相关的标记基因的基因型纯合性增加的证据。本文将回顾微丝虫的生物学,以及针对丝虫感染的诊断测试的发展。将讨论大环内酯对微丝虫行为和存活的影响,以及大环内酯在有或没有经过成年杀虫剂治疗的微丝fil狗中的使用和作用。强力霉素对心丝虫微丝heart的作用,最佳测试方法以及在成年杀虫剂治疗和微丝杀螨治疗后验证微丝aria的有效清除率,从而使狗不再是其他狗的潜在感染源

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号